Our findings show that in LAM, depleting pDCs inhibits Th17 differentiation in helper T cells and reduces survival after CpG-ODN-mediated TLR9 activation, suggesting that pDCs play a beneficial role in this disease. The gene discussed is TLR9; the disease is lymphangioleiomyomatosis.